Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

"They can shut the PSA trial down now, not going anywhere."

Mastiff, how is this statement neutral? It sounds very negative to me, especially considering the initial data look positive, as it appears the combo may be more effective than either PSA or Keytruda alone to treat prostate cancer.